Curetis to Use MDx Platform for Cempra Pneumonia Drug Trial
August 09, 2012
Curetis to Use MDx Platform for Cempra Pneumonia Drug Trial
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- EliTech to Distribute Curetis Unyvero Products in Belgium, Luxembourg
March 6, 2013 / GenomeWeb Daily News - Eyeing 2014 FDA Submission for Unyvero System, Curetis Starts Clinical Trial
December 6, 2012 / GenomeWeb Daily News - Transgenomic, NYU-Langone Partner to Study NSCLC Using Ice-Cold-PCR
September 4, 2012 / GenomeWeb Daily News - Germany's Curetis Begins Clinical Trial for MDx Platform, Pneumonia Test Cartridge
March 1, 2012 / PCR Insider - Quidel Acquires BioHelix for $10M Plus Milestones
May 7, 2013 / GenomeWeb Daily News